OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acquired chemoresistance can lead to increased resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus
Dakota W. Goad, Christian Bressy, Molly C. Holbrook, et al.
Molecular Therapy — Oncolytics (2021) Vol. 24, pp. 59-76
Open Access | Times Cited: 10

Showing 10 citing articles:

IFITM protein regulation and functions: Far beyond the fight against viruses
Nela Friedlová, Filip Kokáš, Ted R. Hupp, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33

The Multifaceted Role of miR-21 in Pancreatic Cancers
Clare Chen, Lusine Demirkhanyan, Christopher S. Gondi
Cells (2024) Vol. 13, Iss. 11, pp. 948-948
Open Access | Times Cited: 4

An Extensive Review on Preclinical and Clinical Trials of Oncolytic Viruses Therapy for Pancreatic Cancer
Maryum Nisar, Rehan Zafar Paracha, Sidra Adil, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12

The duality of STAT2 mediated type I interferon signaling in the tumor microenvironment and chemoresistance
Jorge Canar, Kennedy Darling, Ryan Dadey, et al.
Cytokine (2022) Vol. 161, pp. 156081-156081
Open Access | Times Cited: 9

Gemcitabine and Pin1 siRNA co-delivery with fucoidan-coated nano-liposomes for therapy of pancreatic cancer
Zhenjiang Zheng, Dingchuan Peng, Mengfei Li, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 87, pp. 104872-104872
Closed Access | Times Cited: 5

Personalizing Oncolytic Immunovirotherapy Approaches
Georgios M. Stergiopoulos, Ianko Iankov, Evanthia Galanis
Molecular Diagnosis & Therapy (2023) Vol. 28, Iss. 2, pp. 153-168
Closed Access | Times Cited: 3

Intertumoral heterogeneity impacts oncolytic vesicular stomatitis virus efficacy in mouse pancreatic cancer cells
Dakota W. Goad, Anna Y. Nesmelova, Laurel R. Yohe, et al.
Journal of Virology (2023) Vol. 97, Iss. 9
Open Access | Times Cited: 2

Role of interferon-induced transmembrane protein family in cancer progression: a special focus on pancreatic cancer
Peipei Wang, Yan Pan, Yu Zhang, et al.
Medical Oncology (2024) Vol. 41, Iss. 4
Closed Access

Recombinant VSVs: A Promising Tool for Virotherapy
K A Vorona, V. D. Moroz, N. B. Gasanov, et al.
Acta Naturae (2024) Vol. 16, Iss. 4, pp. 4-14
Closed Access

Lnc-ing epigenetic mechanisms with autophagy and cancer drug resistance
Sandhik Nandi, Atanu Mondal, Aritra Ghosh, et al.
Advances in cancer research (2023), pp. 133-203
Closed Access

Page 1

Scroll to top